Causes & Subtypes of Gastroparesis
At a Glance
Gastroparesis is primarily caused by three factors: idiopathic triggers (often following a viral infection), diabetes (damaging the vagus nerve), and surgical injury. Medications like GLP-1 agonists (Ozempic) and opioids can also mimic or worsen the condition by slowing stomach emptying.
Gastroparesis is not a single disease, but a symptom of many different underlying issues. Identifying your specific subtype or etiology (the cause) is a crucial first step, as it helps your medical team predict your outlook and choose the best management strategies [1][2].
The Big Three: Most Common Causes
Most cases of gastroparesis fall into one of these three categories:
- Idiopathic Gastroparesis (approx. 58–63%): This is the most common subtype [3][1]. “Idiopathic” means the exact cause is unknown. However, many patients in this group report that their symptoms started suddenly after a viral illness, suggesting a post-viral cause where the infection may have temporarily or permanently affected the stomach’s nerves [4]. These patients often report more abdominal pain and feeling full quickly [2].
- Diabetic Gastroparesis (approx. 23–24%): This occurs when long-term high blood sugar damages the vagus nerve [3][5]. It is more common in Type 1 than Type 2 diabetes and is often associated with other complications like retinopathy (eye issues) or neuropathy (numbness in hands/feet) [6]. Patients with this type often experience more severe nausea and vomiting [3][2].
- Post-Surgical Gastroparesis (approx. 11%): This is caused by accidental injury to the vagus nerve during an operation [3]. While it can happen with many abdominal surgeries, the highest risks are seen with lung transplants (up to 57–67%), esophagectomies, and pancreatic surgeries [7][8][9]. It can also occur after Nissen fundoplication (reflux surgery), though it is often temporary [10][11].
Medication-Induced Gastroparesis
Certain modern medications can slow your digestion so much that they mimic or cause gastroparesis.
- GLP-1 Agonists: These medications (such as Ozempic, Wegovy, and Mounjaro) work partly by intentionally slowing down the stomach to help with weight loss and blood sugar [12][13]. For some, this slowing becomes severe [14].
- Is it Reversible? In many cases, the delayed emptying caused by these drugs is reversible once the medication is stopped, though it may take several weeks for the effect to wear off [15][16].
- Opioids: Narcotic pain medications are well-known to slow the entire digestive tract and can significantly worsen existing gastroparesis [4].
Rare & Atypical Causes
While less common, other conditions can lead to “stomach paralysis”:
- Connective Tissue Diseases (approx. 5%): Conditions like Scleroderma or Lupus (SLE) can cause the stomach muscles to become stiff or scarred [3][17][4]. These patients often report significant bloating and abdominal distension [3].
- Neurological Disorders: Parkinson’s Disease is a frequent cause, with some degree of slow emptying affecting up to 70–100% of patients [18][19]. In these cases, the issue is usually with the brain’s signals to the stomach rather than the stomach itself [20].
- Paraneoplastic Syndrome: Very rarely, certain types of cancer can cause the immune system to attack the nerves in the digestive tract [4].
Common questions in this guide
What is the most common cause of gastroparesis?
Can diabetes cause gastroparesis?
Do medications like Ozempic cause gastroparesis?
Is medication-induced gastroparesis reversible?
Can surgery trigger gastroparesis?
Related questions
Get notified when new evidence is published on Gastroparesis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (20)
- 1
Effect of Domperidone Therapy on Gastroparesis Symptoms: Results of a Dynamic Cohort Study by NIDDK Gastroparesis Consortium.
Sarosiek I, Van Natta M, Parkman HP, et al.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022; (20(3)):e452-e464 doi:10.1016/j.cgh.2021.05.063.
PMID: 34089855 - 2
Diabetic Gastroparesis and Nondiabetic Gastroparesis.
Shen S, Xu J, Lamm V, et al.
Gastrointestinal endoscopy clinics of North America 2019; (29(1)):15-25 doi:10.1016/j.giec.2018.08.002.
PMID: 30396524 - 3
Atypical Causes of Gastroparesis: Prevalence, Gastric Emptying, and Clinical Features.
Szeto L, Yazdian A, Parkman HP
Journal of clinical gastroenterology 2023; (57(9)):895-900 doi:10.1097/MCG.0000000000001786.
PMID: 36730846 - 4
Pharmacologic treatments for gastroparesis.
Camilleri M, Jencks KJ
Pharmacological reviews 2025; (77(2)):100019 doi:10.1016/j.pharmr.2024.100019.
PMID: 40148033 - 5
Autonomic function in gastroparesis and chronic unexplained nausea and vomiting: Relationship with etiology, gastric emptying, and symptom severity.
Nguyen L, Wilson LA, Miriel L, et al.
Neurogastroenterology and motility 2020; (32(8)):e13810 doi:10.1111/nmo.13810.
PMID: 32061038 - 6
Key variables associated with gastroparesis in diabetes patients with gastroparesis-like symptoms.
Bekkelund M, Steinsvik EK, Valeur J, et al.
Scandinavian journal of gastroenterology 2025; (60(9)):865-873 doi:10.1080/00365521.2025.2531038.
PMID: 40650418 - 7
Lung transplantation delays gastric motility in patients without prior gastrointestinal surgery-A single-center experience of 412 consecutive patients.
Hirji SA, Gulack BC, Englum BR, et al.
Clinical transplantation 2017; (31(10)) doi:10.1111/ctr.13065.
PMID: 28758244 - 8
Considerations and Indications for Gastric Emptying Scintigraphy in Lung Transplant Patients.
Sisti JD, Bolet SI, Amanullah A, et al.
Asia Oceania journal of nuclear medicine & biology 2025; (13(1)):53-61 doi:10.22038/aojnmb.2024.80821.1572.
PMID: 39744049 - 9
Association of pylorus preservation with outcomes of pancreaticoduodenectomy across the United States.
Mahrokhi S, Sakowitz S, Aguayo E, et al.
Surgery open science 2025; (28()):36-42 doi:10.1016/j.sopen.2025.10.005.
PMID: 41244994 - 10
Transient delayed gastric emptying following laparoscopic Nissen fundoplication for gastroesophageal reflux disease.
He S, Jia Y, Xu F, et al.
Langenbeck's archives of surgery 2021; (406(5)):1397-1405 doi:10.1007/s00423-021-02156-2.
PMID: 33825044 - 11
Minimally invasive Roux-en-Y reconstruction as a salvage operation after failed nissen fundoplication.
Landreneau JP, Strong AT, Kroh MD, et al.
Surgical endoscopy 2020; (34(5)):2211-2218 doi:10.1007/s00464-019-07010-7.
PMID: 31346753 - 12
The Clinical Application of GLP-1RAs and GLP-1/GIP Dual Receptor Agonists Based on Pharmacological Mechanisms: A Review.
Liu Z, Yu S, Jin X, et al.
Drug design, development and therapy 2025; (19()):10383-10409 doi:10.2147/DDDT.S559919.
PMID: 41312047 - 13
Gastrointestinal Motility Effects of GLP-1 Receptor Agonists.
Bellavance D, Chua S, Mashimo H
Current gastroenterology reports 2025; (27(1)):49 doi:10.1007/s11894-025-00995-3.
PMID: 40622491 - 14
Gastrointestinal and Hepatobiliary Safety of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes.
Niu C, Sun K, Zhang J, et al.
The American journal of gastroenterology 2025; doi:10.14309/ajg.0000000000003760.
PMID: 40900093 - 15
Efficacy and safety of semaglutide for weight management: evidence from the STEP program.
Amaro A, Sugimoto D, Wharton S
Postgraduate medicine 2022; (134(sup1)):5-17 doi:10.1080/00325481.2022.2147326.
PMID: 36691309 - 16
Worsening vasomotor symptoms in the setting of estradiol and semaglutide: a case report.
Parker AE
Menopause (New York, N.Y.) 2025; doi:10.1097/GME.0000000000002621.
PMID: 40729307 - 17
Gastroparesis in Non-Diabetics: Associated Conditions and Possible Risk Factors.
Nassar Y, Richter S
Gastroenterology research 2018; (11(5)):340-345 doi:10.14740/gr1060w.
PMID: 30344804 - 18
Parkinson's Disease and Diabetes Mellitus: Synergistic Effects on Pathophysiology and GI Motility.
Yan Y, Shimoga D, Sharma A
Current gastroenterology reports 2023; (25(5)):106-113 doi:10.1007/s11894-023-00868-7.
PMID: 37067721 - 19
Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence.
Pellegrini C, Antonioli L, Colucci R, et al.
Parkinsonism & related disorders 2015; (21(12)):1407-14.
PMID: 26499757 - 20
Gastric dysmotility in Parkinson's disease is not caused by alterations of the gastric pacemaker cells.
Heimrich KG, Jacob VYP, Schaller D, et al.
NPJ Parkinson's disease 2019; (5()):15 doi:10.1038/s41531-019-0087-3.
PMID: 31372495
This guide explains the causes and subtypes of gastroparesis for educational purposes only. Always consult your gastroenterologist for proper diagnosis and management of your specific condition.